BioNTech SE (22UA.F)

EUR 94.05

(4.04%)

Inventory Summary of BioNTech SE

BioNTech SE's latest annual inventory in 2023 was 357.7 Million EUR , down -18.63% from previous year.
BioNTech SE's latest quarterly inventory in 2024 Q1 was 345.72 Million EUR , down -3.35% from previous quarter.
BioNTech SE reported annual inventory of 439.6 Million EUR in 2022, down -12.52% from previous year.
BioNTech SE reported annual inventory of 502.5 Million EUR in 2021, up 683.69% from previous year.
BioNTech SE reported quarterly inventory of 340.3 Million EUR for 2024 Q2, down -1.57% from previous quarter.
BioNTech SE reported quarterly inventory of 415.7 Million EUR for 2023 Q3, down -7.4% from previous quarter.

Annual Inventory Chart of BioNTech SE (2023 - 2016)

Historical Annual Inventory of BioNTech SE (2023 - 2016)

Year	Inventory	Inventory Growth
2023	357.7 Million EUR	-18.63%
2022	439.6 Million EUR	-12.52%
2021	502.5 Million EUR	683.69%
2020	64.12 Million EUR	447.01%
2019	11.72 Million EUR	102.49%
2018	5.78 Million EUR	49.36%
2017	3.87 Million EUR	18.68%
2016	3.26 Million EUR	0.0%

Year	Inventory	Inventory Growth
2024 Q1	345.72 Million EUR	-3.35%
2024 Q2	340.3 Million EUR	-1.57%
2023 Q3	415.7 Million EUR	-7.4%
2023 FY	357.7 Million EUR	-18.63%
2023 Q2	448.9 Million EUR	5.85%
2023 Q1	424.1 Million EUR	-3.53%
2023 Q4	357.7 Million EUR	-13.95%
2022 Q4	439.6 Million EUR	49.12%
2022 FY	439.6 Million EUR	-12.52%
2022 Q3	294.8 Million EUR	-19.83%
2022 Q2	367.7 Million EUR	-19.94%
2022 Q1	459.3 Million EUR	-8.6%
2021 Q4	502.5 Million EUR	27.73%
2021 Q1	146.9 Million EUR	129.1%
2021 Q3	393.4 Million EUR	28.81%
2021 Q2	305.4 Million EUR	107.9%
2021 FY	502.5 Million EUR	683.69%
2020 Q3	12.36 Million EUR	43.56%
2020 Q1	9.62 Million EUR	-17.86%
2020 FY	64.12 Million EUR	447.01%
2020 Q4	64.12 Million EUR	418.43%
2020 Q2	8.61 Million EUR	-10.53%
2019 Q1	- EUR	-100.0%
2019 FY	11.72 Million EUR	102.49%
2019 Q4	11.72 Million EUR	7.85%
2019 Q2	7.27 Million EUR	0.0%
2019 Q3	10.86 Million EUR	49.32%
2018 FY	5.78 Million EUR	49.36%
2018 Q4	5.78 Million EUR	0.0%
2018 Q1	- EUR	0.0%
2017 FY	3.87 Million EUR	18.68%
2016 FY	3.26 Million EUR	0.0%

Peer Inventory Comparison of BioNTech SE

Name	Inventory	Inventory Difference
CureVac N.V.	24.82 Million EUR	-1341.092%
Biotest Aktiengesellschaft	419.1 Million EUR	14.65%
Biotest Aktiengesellschaft	419.1 Million EUR	14.65%
BRAIN Biotech AG	9.72 Million EUR	-3577.771%
Formycon AG	467 Thousand EUR	-76495.289%
Heidelberg Pharma AG	10.48 Million EUR	-3310.632%
Medigene AG	1.00 EUR	-35769999900.0%